Intratumoral Combo Shrinks Melanomas Refractory to Anti-PD-1 But response rate driven primarily by injected lesions, expert points out Apr 14, 2022
Pre-Op TNF Blockers Cleared of Infection Risk in IBD Patients Largest prospective cohort study finds no increase in postoperative infections Apr 14, 2022
Cardiovascular Risk in Patients With Psoriasis Andrew Blauvelt, MD, leads a roundtable discussion with Joel Gelfand, MD, and Neil Korman, MD Apr 14, 2022 video
African Ancestry Reduces Risk From APOE Gene in Alzheimer's Farid Rajabli, PhD, explains the protective effect of an African ancestral background Apr 14, 2022 video
Vision-Threatening Retinal Condition Linked to COVID-19 Rates of rare retinal vein occlusion jumped after infection, although overall numbers remain low Apr 14, 2022
Anti-CD39 Combination Therapy Promising in Gastric/GEJ Cancer Responses in a majority of patients, evidence of durability with TTX-030, chemoimmunotherapy Apr 14, 2022
7 Wartime Medical Advancements How conflict spurred innovation in antibiotics, chemotherapy, and more Apr 14, 2022
Achilles' Tendon Rupture Surgery Not So Necessary? Randomized trial suggests one advantage despite similar outcomes to nonoperative treatment Apr 13, 2022
BTK Inhibitor Shows Potential in Immune Thrombocytopenia Across doses, 40% of heavily pretreated patients responded to oral rilzabrutinib Apr 13, 2022
Pricier, Questionable Bone Density Scan Growing in Use QCT delivers far more radiation and exaggerates spinal bone loss, so why is it on the rise? Apr 13, 2022
Two Bone Scans Three Weeks Apart, Results in Reverse Discordant QCT, DXA results confuse patients and doctors, "How can they both be right?" Apr 13, 2022
What Proportion of Doctors Are Vaccine Hesitant? Researchers conducting a new survey said the answer was far higher than expected Apr 13, 2022
'We're Sorry, You Did Not Match to Any Position' While initially shocked, my disbelief was quickly replaced by relief and gratitude Apr 13, 2022
Dual Immunotherapy Improves PFS in Melanoma Resistant to Anti-PD-1 Six-month PFS rate more than doubled with nivolumab/ipilimumab versus ipilimumab alone Apr 13, 2022
Response in Kids With Psoriasis Maintained Long Term With IL-17A Inhibitor At least 75% improvement at 108 weeks in patients treated with ixekizumab Apr 13, 2022
Are My Coping Skills a Result of My Emergency Medicine Training? Adrienne Van Curen, MD, advises learning to accept what you can't control Apr 12, 2022
Home Walking Program Eases Peripheral Artery Disease Limitations Randomized trial shows modest impact even without in-facility supervision Apr 12, 2022
Meningitis B Vaccine May Protect Against ... Gonorrhea? Evidence from the U.S. and Australia indicates vaccine provides modest protection Apr 12, 2022
Meet This Year's Healthcare Billionaires HCA founder and Cook Group medical device developer make 2022 list of Forbes Billionaires Apr 12, 2022
Nurse Practitioners in New York Granted Full Practice Authority State budget removes need for formal, documented relationships between NPs and MDs, facilities Apr 12, 2022
Boosting Responses to Neoadjuvant Therapy in Resectable NSCLC Multi-drug platform study identifies promising durvalumab-based combinations Apr 12, 2022
Neoadjuvant Nivolumab a 'New Standard' in Lung Cancer "Another quantum leap in lung cancer therapy," expert says Apr 12, 2022
Genetic Score Shows Promise for Honing PSA Precision Fewer unnecessary biopsies projected with use of genetics-adjusted values Apr 12, 2022
Overall, Post-COVID Vax Myocarditis Rates Similar to Other Vaccines 75-year literature review finds incidence comparable to non-COVID vaccines Apr 11, 2022
Kirsten Bibbins-Domingo Named Editor-in-Chief of JAMA Journal's first Black leader vows to restore trust following last year's podcast debacle Apr 11, 2022
Antenatal Steroids May Pose Neurologic Risk to Babies Born Full Term Birth timing -- not just dose timing -- linked to safety and efficacy of antenatal steroids Apr 11, 2022
Fixing One Thing at a Time How can we make sure our patients get the screenings they need? Here are a few ideas Apr 11, 2022
PARP Inhibitor-Based Triplet Promising in Endometrial Cancer Olaparib/cyclophosphamide/metformin combo appears effective in older, heavily pretreated patients Apr 11, 2022
Longer-Term Sotorasib Data 'Encouraging' in KRAS-Mutated NSCLC Prolonged tumor response seen in 2-year analysis Apr 11, 2022
DCIS Recurrence Often Represents a New Primary Breast Cancer Almost a fifth of cases unrelated to primary DCIS, raising questions about current treatment Apr 11, 2022
Visual Disturbances After Each COVID-19 Shot? Rare sequence of ischemic optic neuropathy in both eyes after first and second doses Apr 11, 2022
PPIs Linked to Better Survival for One Group With Cirrhosis Large VA study shows potential benefit for one group, risk for the rest Apr 11, 2022
Clinical Challenges: Implementing More Guideline-Endorsed SGLT2i Use New strategies needed to ensure all are on board with fourth pillar of HF treatment Apr 11, 2022
Bispecific Antibody-NK Cell Complex Impresses in Early Hodgkin/NHL Trial Objective responses in 89% of patients with no CRS, neurotoxicity, or graft-versus-host disease Apr 11, 2022
Optimize Muslim Patient Health by Learning About Ramadan Cultural understanding goes a long way in care Apr 10, 2022
Novel Agents Promising in Pruritus, Rare Metabolic Disease, and More A round-up of noteworthy research from the NKF Spring Clinical Meetings Apr 10, 2022
Novel Drug Cuts Proteinuria in APOL1-Mediated Kidney Disease Significant UPCR reductions in just a few weeks in phase II study Apr 10, 2022
Even With CKD, Patiromer Helped Heart Failure Patients Keep Hyperkalemia at Bay Promising findings from prespecified renal analysis of the DIAMOND trial Apr 09, 2022
Tufts Nurses Rally for Children's Access to Care as Closure Looms "It's really scary and heartbreaking to think about when we're not an option" Apr 08, 2022
